BioCentury
ARTICLE | Company News

Epiphany, University of Erlangen-Nuermberg deal

January 5, 2009 8:00 AM UTC

Epiphany acquired a patent from the university covering Kaposi's sarcoma-associated herpesvirus (KSHV) glycoprotein K8.1, a polypeptide component of human herpesvirus 8 (HHV-8), the cause of Kaposi's...